Online citations, reference lists, and bibliographies.
← Back to Search

An Investigation Of Adequate Volume For The Diagnosis Of Malignancy In Pleural Fluids

S. Thomas, L. Davidson, M. McKean
Published 2011 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
S. C. Thomas, L. R. R. Davidson and M. E. McKean
This paper references



This paper is referenced by
10.1111/crj.12619
Positive pleural cytology is an indicator for visceral pleural invasion in metastatic pleural effusions
M. Froudarakis (2018)
10.1111/cyt.12808
Number of mesothelial cells as a measure of adequacy criteria for pleural effusions: A multi‐institutional study
Erika F. Rodriguez (2020)
10.2217/fon.11.45
Diagnostic molecular biomarkers for malignant pleural effusions.
K. Sriram (2011)
10.1183/13993003.00349-2018
ERS/EACTS statement on the management of malignant pleural effusions
A. Bibby (2018)
10.1002/cncy.21452
A minimum fluid volume of 75 mL is needed to ensure adequacy in a pleural effusion: A retrospective analysis of 2540 cases
Lisa M. Rooper (2014)
Management of malignant pleural effusion
R. Boshuizen (2017)
10.1016/j.annpat.2015.08.019
[Pre-analytical quality in fluid samples cytopathology: Results of a survey from the French Society of Clinical Cytology].
M. Courtade-Saïdi (2015)
10.1111/j.1440-1843.2012.02128.x
Year in review 2011: Respiratory infections, tuberculosis, pleural diseases, bronchoscopic intervention and imaging
J. M. Porcel (2012)
10.1016/J.ANNPAT.2015.08.019
Qualité pré-analytique en cytopathologie des liquides biologiques : résultats d’une enquête de la Société française de cytologie clinique
Monique Courtade-Saïdi (2015)
Diagnostic Yield of Pleural Fluid Cytology in Malignant Pleural Effusion
M. Asim (2016)
10.1016/j.jasc.2020.04.001
Collection and Handling of Thoracic Small Biopsy and Cytology Specimens for Ancillary Studies Guideline from the College of American Pathologists (CAP): implications for the cytology community.
P. VanderLaan (2020)
10.5858/arpa.2020-0119-CP
Collection and Handling of Thoracic Small Biopsy and Cytology Specimens for Ancillary Studies: Guideline From the College of American Pathologists in Collaboration With the American College of Chest Physicians, Association for Molecular Pathology, American Society of Cytopathology, American Thoracic
S. Roy-Chowdhuri (2020)
10.1093/ajcp/aqaa058
Suspicious for Malignancy Diagnoses on Pleural Effusion Cytology.
E. Rodriguez (2020)
10.1111/cyt.12755
A 2‐year retrospective study on pleural effusions: A cancer centre experience
E. Valerio (2019)
10.1007/978-3-030-53908-5
The International System for Serous Fluid Cytopathology
A. Chandra (2020)
10.1002/dc.24653
Root cause analysis of indeterminate diagnoses in serous fluids cytopathology.
Hamza N. Gokozan (2020)
10.1093/ajcp/aqv021
A Minimum Volume of More Than 60 mL Is Necessary for Adequate Cytologic Diagnosis of Malignant Pericardial Effusions.
Lisa M. Rooper (2016)
10.1186/s13000-015-0290-4
Assessment of a panel of tumor markers for the differential diagnosis of benign and malignant effusions by well-based reverse phase protein array
T. Braunschweig (2015)
10.1055/s-0034-1395795
Current controversies in the management of malignant pleural effusions.
M. Azzopardi (2014)
10.1016/J.JASC.2016.04.004
A specimen volume of ≥80 mL improves cytologic sensitivity for malignant ascites: a retrospective analysis of 2665 cases.
Lisa M. Rooper (2016)
10.1016/j.jasc.2020.05.015
The international system for reporting serous fluid cytopathology-diagnostic categories and clinical management.
D. Pinto (2020)
10.5336/CARDIOSCI.2018-63647
Analysis of Pleural Effusion Cases Diagnosed with Uniportal Video Assisted Thoracoscopic Surgery
M. A. Haberal (2019)
10.1016/J.EHMC.2013.02.001
Diagnosis of Pleural Effusions
J. M. Porcel (2013)
10.1093/ejcts/ezy258
ERS/EACTS statement on the management of malignant pleural effusions
A. Bibby (2019)
10.1007/978-3-030-53908-5_2
Non-diagnostic (ND) and Adequacy
M. Saieg (2020)
Semantic Scholar Logo Some data provided by SemanticScholar